chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient came in for the new Pfizer Bivalent vaccine and received the Pfizer monovalent vaccine instead.  Nurse checked with me when she got a lot number that did not match the computers' record and I went back to the vaccine room to doublecheck.  I then found that the bivalent vaccine had the matching lot number and brought  it back to the clinic, but the nurse had already vaccinated the patient.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered vaccine after expiration date.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Flushing, Heart rate increased
Clinical narrative: Pt explained that she felt flush, and had rapid heartbeat after receiving injection. Recovered soon after
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered vaccine after published expiration date 07/07/2022 in error. we failed to read the fine print on the packing slip and thought that the expiration date was the place code. we have  taken corrective measure for this error not to happen again. We have also contacted Moderna and their team is conducting analysis concerning this patient for a product assesment.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal disorder
Clinical narrative: I haven't been able to use my right arm that well since the shot
Age: 27.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Abdominal pain, Abdominal pain upper, Headache, Nausea, Pyrexia
Clinical narrative: The night of I experienced mild fever/ headache that lasted to the next day  5 days after the injection I began experiencing abdominal pains, nausea, and headaches every other day.   Wednesday was slight stomach ache Thursday was intense stomach ache, nausea, retching Friday was mild stomach ache Saturday was intense stomach aches, nausea, retching Sunday was fine, perhaps slight stomach ache Monday was uncomfortable stomach ache but not as intense as previously experienced, nausea  Tuesday, Wednesday, Thursday, Friday, mild to no symptoms.  Hard to tell.
Age: 27.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Retching
Clinical narrative: The night of I experienced mild fever/ headache that lasted to the next day  5 days after the injection I began experiencing abdominal pains, nausea, and headaches every other day.   Wednesday was slight stomach ache Thursday was intense stomach ache, nausea, retching Friday was mild stomach ache Saturday was intense stomach aches, nausea, retching Sunday was fine, perhaps slight stomach ache Monday was uncomfortable stomach ache but not as intense as previously experienced, nausea  Tuesday, Wednesday, Thursday, Friday, mild to no symptoms.  Hard to tell.
Age: 66.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Blood test normal, Headache, Pyrexia
Clinical narrative: Fever of 101.5 commenced at about 9 am on 28 Sept 2022, almost one week after the covid and flu vaccines were administered. Fever abated about 7pm that same day but a slight headache remained.  Took ibuprofen during the day. The fever returned the next few evenings accompanied by slight headache, but I didn't record the temperature or the days; took ibuprofen.   Fever recordings I did make are as follows:  100.4 at 7 pm on 3 Oct 2022; resolved by next morning but a slight headache remained until noon.  Took ibuprofen. Telemedicine visit on 4 Oct 2022 with Physicians Assistant; prescribed Amoxicillin 875 mg, 2 tablets daily for 10 days. 100.4 at 7 pm on 9 Oct 2022; resolved by next morning but a slight headache remained for the morning. Took ibuprofen. No fever 10 Oct or 11 Oct 99.5  at 10 pm on 12 Oct 2022; resolved by next morning but a slight headache remained for the morning. Took ibuprofen. No fever 13 Oct thru 18 Oct 99.7  at 10 pm on 19 Oct 2022; resolved by next morning but a slight headache remained for the morning. Took ibuprofen.
Age: 50.0
Sex: M
Vaccine: FLU4, HPV9
Symptoms: Wrong product administered
Clinical narrative: HPV vaccine adminitered in error.
Age: 32.0
Sex: M
Vaccine: UNK
Symptoms: Diarrhoea
Clinical narrative: Severe diarrhea 3 hours after vaccination. Ongoing.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Got COVID.  Tested positive with at-home test.  Nasty sore throat.  Took paxlovid.  Was better after three or four days.  Day five got sick all over again.  Bottom line - two-to-three weeks before feeling normal and testing negative with at home tests.
Age: 38.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT HAD NOT COMPLETED A PRIMARY SERIES AND WAS GIVEN PFIZER BIVALENT AS HIS SECOND DOSE. PATIENT HAD ONLY RECEIVED 1 PFIZER DOSE PREVIOUSLY.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Hypoaesthesia, Musculoskeletal pain, Pain
Clinical narrative: Patient came in for 2nd dose of Shingles Vaccine, patient received vaccine at about 1:10pm and was  advised to wait 15 min in case of adverse reaction, while waiting in the lobby patient informed receptionist she was having a lot of pain. I approached patient and asked her about her pain, patient stated that her left arm was feeling numb as well as her left leg and indicated that her back (shoulder blade area) was hurting which radiated to her lower back. Patient was brought back at about 1:15pm and Dr. was called to triage patient. 4 sets of vitals were taken 151/87  pulse 87 at 1:15pm, 142/86 pulse 92 at 1:25pm, 142/82 at 1:35pm, and 133/82 pulse 91 at 1:40pm with O2 sat of 96% and temperature of 97.6
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Anxiety, Blood glucose decreased, Dizziness, Hyperhidrosis
Clinical narrative: Guest in post observation for allotted time after receiving 1St first dose of Pfizer.  Guest complained of being dizzy and slumped in chair and then to floor in supine position client did not hit his head.  While on the floor the guest had some posturing movements in upper extremities for what appeared to be a few seconds. Mom states, ?that this has not happened to him before with any shots.?  Once on the floor he cried out and he responded to his name being called by his mother.   At 11:53 R.N.s, responded and started emergency supportive care.  Guest was alert and answering the assessment questions and assessing vital signs was completed as well.  Guest was diaphoretic and pale expressing anxiety about finding himself on the floor. Supported into a sitting position and encouraged to remain on the floor until he was no longer dizzy.  Explained to guest that he was probably experiencing low blood sugar because he and his mother stated that he had not eaten today, and he was hungry when he entered the site.  Juice was offered and accepted- two containers.  Educated guest that the juice was to help elevate blood glucose levels, since he had not eaten this am.   Guest was supported to a sitting position on a chair by R.N.s  11:53 BP 198/88 guest is alert and talking yet pale and diaphoretic. States he is still feeling dizzy, lightheaded and that his stomach was still upset. Cold compress applied to back of the neck and forehead, client conversing and stating that his," stomach is upset."  11:55 BP 160/84 R.N. discussing with guest and mom that having an empty stomach and low blood sugar may cause this response when vaccinated. Mom requesting that 911 be called, and 911 was called Guests was no longer pale and diaphoretic, states,? he felt better,? Mom and guest stated, ?that they were going to go to the food court to get food.?   They were offered an accepted the use of the wheelchair to go to the food court.    Mom voiced concern regarding the usage of 911 and possible expense of this service.   Encouraged to stay and be assessed by EMS before living to go get food.  12:00 Informed that 911 was entering the site. 911 assessed and evaluated and released the guest.   Guest felt better and exited the clinic with use of wheelchair and accompanied with Mother and brother to the food court.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotonia, Pallor, Posturing
Clinical narrative: Guest in post observation for allotted time after receiving 1St first dose of Pfizer.  Guest complained of being dizzy and slumped in chair and then to floor in supine position client did not hit his head.  While on the floor the guest had some posturing movements in upper extremities for what appeared to be a few seconds. Mom states, ?that this has not happened to him before with any shots.?  Once on the floor he cried out and he responded to his name being called by his mother.   At 11:53 R.N.s, responded and started emergency supportive care.  Guest was alert and answering the assessment questions and assessing vital signs was completed as well.  Guest was diaphoretic and pale expressing anxiety about finding himself on the floor. Supported into a sitting position and encouraged to remain on the floor until he was no longer dizzy.  Explained to guest that he was probably experiencing low blood sugar because he and his mother stated that he had not eaten today, and he was hungry when he entered the site.  Juice was offered and accepted- two containers.  Educated guest that the juice was to help elevate blood glucose levels, since he had not eaten this am.   Guest was supported to a sitting position on a chair by R.N.s  11:53 BP 198/88 guest is alert and talking yet pale and diaphoretic. States he is still feeling dizzy, lightheaded and that his stomach was still upset. Cold compress applied to back of the neck and forehead, client conversing and stating that his," stomach is upset."  11:55 BP 160/84 R.N. discussing with guest and mom that having an empty stomach and low blood sugar may cause this response when vaccinated. Mom requesting that 911 be called, and 911 was called Guests was no longer pale and diaphoretic, states,? he felt better,? Mom and guest stated, ?that they were going to go to the food court to get food.?   They were offered an accepted the use of the wheelchair to go to the food court.    Mom voiced concern regarding the usage of 911 and possible expense of this service.   Encouraged to stay and be assessed by EMS before living to go get food.  12:00 Informed that 911 was entering the site. 911 assessed and evaluated and released the guest.   Guest felt better and exited the clinic with use of wheelchair and accompanied with Mother and brother to the food court.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, COVID-19, Cough, Diarrhoea, Discharge
Clinical narrative: I had a fever of 101  for 3 days, sore throat, cough, running nose, congestion, and sneezing. One morning I had diarrhea and one night I had stomach cramps. To stop the diarrhea I took a modem. I test positive at home for COVID-19. I then called my doctor and he prescribed me Paxlovid. I tested negative on 10/04/2022 then tested positive again. I had a headache, sore throat, and coughing. I still have congestion, drainage and really bad sinus pressure.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Paranasal sinus discomfort, Pyrexia, Respiratory tract congestion
Clinical narrative: I had a fever of 101  for 3 days, sore throat, cough, running nose, congestion, and sneezing. One morning I had diarrhea and one night I had stomach cramps. To stop the diarrhea I took a modem. I test positive at home for COVID-19. I then called my doctor and he prescribed me Paxlovid. I tested negative on 10/04/2022 then tested positive again. I had a headache, sore throat, and coughing. I still have congestion, drainage and really bad sinus pressure.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I had a fever of 101  for 3 days, sore throat, cough, running nose, congestion, and sneezing. One morning I had diarrhea and one night I had stomach cramps. To stop the diarrhea I took a modem. I test positive at home for COVID-19. I then called my doctor and he prescribed me Paxlovid. I tested negative on 10/04/2022 then tested positive again. I had a headache, sore throat, and coughing. I still have congestion, drainage and really bad sinus pressure.
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site rash, Rash erythematous
Clinical narrative: Red Rash on arm appeared 3 inches below injection site 3 days after injection.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Hives
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash, Throat tightness
Clinical narrative: rash on face and neck, tightening of throat
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: NO ADVERSE EVENT. WE ARE JUST REPORTING ADMINISTRATION OF THE  VACCINE AFTER RECCOMMENDED  TIME  ROOM TEMPERATUE.  MODERNA MEDICAL TEAM VERIFIED THAT VACCINE WAS STILL EFFECTIVE , AND PT NOTIFIED  FOR OF POTENTIAL FOR SITE INFECTION.             NO ADVERSE EFFECT AT THIS TIME.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: shortness of breath, brain fog, confusion, papular rash with pruritic presentation, fever chills, fatigue
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash papular, Rash pruritic
Clinical narrative: shortness of breath, brain fog, confusion, papular rash with pruritic presentation, fever chills, fatigue
Age: 32.0
Sex: M
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Staff pharmacist administered FLuzone HD to adult under 65 years old. Pt is only 32 years old at time of vaccine was given. Patient was notified on the same day. Patient is doing fine, no side effects at this time. Patient and family member ( dad) was advised to call pharmacy/ MD  if patient experience any symptoms.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: She received her flu vaccine in her left arm  on 10/19/22.  Yesterday she noted erythema at the injection site and it felt warm to touch.  Today, the site is red, about the size of a small orange and it is warm to touch.  Site is tender, per patient report.  Injection site appears to have been placed correctly.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin normal, Glycosylated haemoglobin normal, Laboratory test normal, Psoriasis, Rash
Clinical narrative: Four months after COVID-19 vaccine dose 3, had Shingrix vaccined then developed a rash throughout body; Doctor prescribed Clobetasol Cream, but it didn't help; Doctor then took a Biopsy of Lesions and determined it was Psoriasis; Was prescribed Skyrizi and it seems to be helping.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syringe issue, Underdose
Clinical narrative: Lower-than-authorized dose administered due to medication leaked out of the syringe. Consulted with Dr. and CDC  recommendations for COVID-19 vaccine administration errors and deviations and patient cleared to receive a repeat dose to ensure patient received full dose of vaccine. Patient was educated on this recommendation, patient verbalized understanding and agreed to receive repeat dose.
Age: 65.0
Sex: F
Vaccine: FLUA4
Symptoms: Exostosis, Joint swelling, Pain, Skin warm, Ultrasound scan
Clinical narrative: Woke up in the morning with her ankle swollen, warm to the touch and in extreme pain. Hurt with movement but not touch. Patient went the the ER a few days later after it didn't go away.  Dr ruled out fracture and blood clot. Dr saw bone spurs on X-ray. Told her to ice, elevate, rest and take aspirin and tylenol. Resolved after 1.5 to 2 weeks.
Age: 65.0
Sex: F
Vaccine: FLUA4
Symptoms: X-ray
Clinical narrative: Woke up in the morning with her ankle swollen, warm to the touch and in extreme pain. Hurt with movement but not touch. Patient went the the ER a few days later after it didn't go away.  Dr ruled out fracture and blood clot. Dr saw bone spurs on X-ray. Told her to ice, elevate, rest and take aspirin and tylenol. Resolved after 1.5 to 2 weeks.
Age: 11.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Chills, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: An 11 year old patient arrived with 3 other family members to receive vaccines at a flu/covid clinic. The 11y.o. patient was administered a Pfizer-BioNTech COVID-19 bivalent booster vaccine that has an EUA for use in individuals 12 years of age and older. Upon notification, the mother indicated they didn't believe it to be a significant issue and that the patient would be turning 12 in less than 5 months. During follow-up with the family, the patient's mother noted the patient had experienced a sore arm and mild chills which were consistent with the side effects she experienced after her primary covid vaccine series. Of note, the 11 y.o. patient also received fluarix in the same arm separated by at least 1 inch that day. Patient's reported weight on the consent form is 160lbs. Patient's physician office was notified during business hours the morning after administration of the vaccine after physician contact information was obtained. Physician and nurse were unavailable so a message was left with staff at the office.
Age: 16.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: I accidently gave pt an extra dose of pfizer new bivalent booster shot on 10/21/22 Today. Pt received it on 9/13/2022. There is no harm caused. I informed pt's mom of this incident and explained to her that this is not harmful but unnecessary and she can call if she can have any question.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse event; Received booster pediatric vial (6Y-11Y)  instead of Bivalent Booster; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Received booster pediatric vial (6Y-11Y)  instead of Bivalent Booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Oct-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Received booster pediatric vial (6Y-11Y)  instead of Bivalent Booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Received booster pediatric vial (6Y-11Y)  instead of Bivalent Booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Received booster pediatric vial (6Y-11Y)  instead of Bivalent Booster).    This case pertains to adult patient 4. Concomitant products were not provided. Treatment medication were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-660841 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-Oct-2022: Live follow up received. IRD of initial version updated to 17-OCT-2022. On 17-Oct-2022: Follow-up contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-660841:Adult patient 4
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Atrial fibrillation, Atrial flutter, Blood test, Chest X-ray
Clinical narrative: This happened twice.  Second visit to Medical Center with elevated heart rate after receiving Moderna vaccine.  First time diagnosed with atrial flutter, this reported time with atrial fib.  First time flutter converted with course of IV diltiazem and IV blood thinner.   Diltiazem increased from 240 dose used for high blood pressure to 320 with new script for rivaroxaban, then discharged.  This time fib converted with an IV course of diltiazem, since blood thinner was on board.  New script for Metoprolol, then discharged.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Echocardiogram, Electrocardiogram, Heart rate increased, Hypertension
Clinical narrative: This happened twice.  Second visit to Medical Center with elevated heart rate after receiving Moderna vaccine.  First time diagnosed with atrial flutter, this reported time with atrial fib.  First time flutter converted with course of IV diltiazem and IV blood thinner.   Diltiazem increased from 240 dose used for high blood pressure to 320 with new script for rivaroxaban, then discharged.  This time fib converted with an IV course of diltiazem, since blood thinner was on board.  New script for Metoprolol, then discharged.
Age: 48.0
Sex: M
Vaccine: COVID19-2
Symptoms: Herpes zoster
Clinical narrative: shingles, one week after covid vaccine
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Syringe issue
Clinical narrative: when administering, vaccine shot out side of syringe
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Became very sick that same night after the vaccine, very dizzy, severe joint pain, nausea, headache, vision felt different, brain fog, chills in bed for 2 days, On day 3 developed tingling in hands and feet, felt in face with muscle weakness in legs and arms. Very fatigued hard to do anything, still feeling this way at day 6 from shot.
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Malaise, Muscular weakness, Nausea, Paraesthesia
Clinical narrative: Became very sick that same night after the vaccine, very dizzy, severe joint pain, nausea, headache, vision felt different, brain fog, chills in bed for 2 days, On day 3 developed tingling in hands and feet, felt in face with muscle weakness in legs and arms. Very fatigued hard to do anything, still feeling this way at day 6 from shot.
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Visual impairment
Clinical narrative: Became very sick that same night after the vaccine, very dizzy, severe joint pain, nausea, headache, vision felt different, brain fog, chills in bed for 2 days, On day 3 developed tingling in hands and feet, felt in face with muscle weakness in legs and arms. Very fatigued hard to do anything, still feeling this way at day 6 from shot.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Eczema, Pigmentation disorder, Pruritus, Rash
Clinical narrative: I first noticed a rash; I didn't know what it was at first. I didn't know if it was eczema or psoriasis. I went to see a dermatologist and she confirmed it was eczema. She wanted to start me on a medication, that cost $5000 but my medical insurance was giving me issues at the time, so I had to wait from January all the way to July to get it and it had been getting worse. She finally started treating me and the eczema was changing the pigment of the skin. It itches all over arms, back of knees, elbows, and hands. She was giving me a 300ml injection of Dupixent. The itching didn't subside until about 1 and a half later. Now I'm self-administering the medication every two weeks. She also put me on Triamcinolone acetonide and  Pimecrolimus. I received many other vaccines and have never had a reaction like this.
Age: 12.0
Sex: M
Vaccine: ANTH
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Effective beyond the administered day.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Condition aggravated, Eczema, Gait disturbance, Musculoskeletal disorder
Clinical narrative: I had a sore arm on vaccination site. The second day my thighs were really sore. Three to fours day later my rheumatoid arthritis started acting up and my hand is stuck, my joints are inflamed that haven't been before, my vertigo also got really bad that I had to crawl to get anywhere, and eczema on the arm I received my shot. I talked to my doctor and she put me back on prednisone.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rheumatoid arthritis, Vaccination site pain, Vertigo
Clinical narrative: I had a sore arm on vaccination site. The second day my thighs were really sore. Three to fours day later my rheumatoid arthritis started acting up and my hand is stuck, my joints are inflamed that haven't been before, my vertigo also got really bad that I had to crawl to get anywhere, and eczema on the arm I received my shot. I talked to my doctor and she put me back on prednisone.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave bivalent for 12+ instead of 5-11
Age: 36.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Effective beyond the administered day.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Effective beyond the administered day.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Bundle branch block left, Electrocardiogram abnormal
Clinical narrative: I had my vaccination on 04/01/2022. In 08/2022 I had an abnormal EKG. This indicated I had a Left Posterior Vesicular Block. I was asymptomatic. I have a follow up with my cardiologist in 11/2022.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Syringe issue
Clinical narrative: vaccinated pt with flu shot.  upon withdrawal of syringe, vaccine squirted out of pt's arm
Age: 60.0
Sex: M
Vaccine: COVID19-2, UNK
Symptoms: Cough, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: Congestion, headache, runny nose,  sore throat, fatigue, cough No treatment Symptoms have subsided after 11 days
Age: 60.0
Sex: M
Vaccine: COVID19-2, UNK
Symptoms: Rhinorrhoea
Clinical narrative: Congestion, headache, runny nose,  sore throat, fatigue, cough No treatment Symptoms have subsided after 11 days
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, Wrong product administered
Clinical narrative: Patient was given moderna booster today instead of shingles. They had a previous Pfizer booster on 9/22/22.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Nausea, Vomiting
Clinical narrative: Pt. became flushed, reporting she felt hot, then had 1 episode of emesis. Provided cool rag and water, nausea subsided after about 15 minutes.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chapped lips, Lip swelling
Clinical narrative: Lips extremely chapped and swollen
Age: 25.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was administered Moderna Bivalent booster dose as a primary administration. He had not received any primary doses prior to this vaccination. Patient waited 15 minutes after administration without any adverse reaction. We contacted patient an hour later and still denied any adverse reaction. Instructed patient to call clinic with any question or concerns.
Age: 93.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperventilation, Nervousness
Clinical narrative: Patient given Pfizer Bivalent dose in-home. No reaction during 15min observation period. Team was about to depart when relative came running for them for assistance. Lead RN saw that patient seemed to be having some hyperventilation and a nervous disposition. Incident protocol activated.  VS ~1130: HR 65, RR 17, O2 89%, BP 90/70. VS ~1135: HR 90, RR 18, O2 90%, BP 108/72. Pulses strong, PMHx AFib, PMHx Congestive Heart Failure.  Family gave in-home supplemental oxygen, PRN Rx albuterol, & PRN Rx anxiolytics. Bed elevated to 30+ degrees. Lead RN considered VS and assessments within context of PMHx. Team remained with patient for an additional 30minutes. VS stable and no assessment of anaphylaxis or cardiorespiratory failure. Family educated to call 911 if S/S resume.
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test normal, Computerised tomogram normal, Photopsia, Vision blurred, Visual impairment
Clinical narrative: On 10/17/22 about 1 p.m. I began to have blurred and fading vision, most notably in left eye, followed by dancing lights around the edges of my field of vision.  The ocular dysfunction lasted only about 30 minutes. PCP advised me to go to ER where an IV was started.  I was seen by Dr. who diagnosed a possible ocular migraine.  Blood work and a CT scan were normal.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product preparation issue
Clinical narrative: this is a booster, one time shot,  The stock vial was not diluted prior to drawing 0.2ml into the syringe for dispensing.  As of 10/21/22 the father has indicated there are no known side effects.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse side effects noted.
Age: 1.58
Sex: F
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Product preparation issue
Clinical narrative: Given non diluted dose
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Confusional state, Cough
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/9/2022 Discharge Date: Oct 20, 2022  PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1] Acute on chronic encephalopathy likely toxic/metabolic in setting of COVID-19 infection exacerbated by underlying dementia HOSPITAL COURSE: Patient is 87-year-old male with the a PMH significant for BPH, hypothyroidism, insomnia and recent declining mentation over the last year is transferred to Hospital on 10/09 due to generalized weakness.  Normally patient is able to ambulate using a walker in his assisted living facility but suddenly was not able to stand up or bear weight and was noted to be more confused and perseverating on certain things.  He was noted to be febrile, tachypneic in ER by chest x-ray was negative.  He tested positive for COVID-19 and was admitted. From a COVID-19 standpoint, patient was neither hypoxic nor had any infiltrates on chest x-ray.  His symptoms of cough and runny nose, unclear date of onset.  After discussion with family, patient will receive 3 day course of remdesivir with close monitoring of  liver function tests. PT/OT evaluated patient and recommended subacute rehab.  He was out of COVID isolation 10/19/22. Patient was discharged in stable condition to SAR.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Liver function test, Metabolic encephalopathy, Pyrexia, Rhinorrhoea
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/9/2022 Discharge Date: Oct 20, 2022  PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1] Acute on chronic encephalopathy likely toxic/metabolic in setting of COVID-19 infection exacerbated by underlying dementia HOSPITAL COURSE: Patient is 87-year-old male with the a PMH significant for BPH, hypothyroidism, insomnia and recent declining mentation over the last year is transferred to Hospital on 10/09 due to generalized weakness.  Normally patient is able to ambulate using a walker in his assisted living facility but suddenly was not able to stand up or bear weight and was noted to be more confused and perseverating on certain things.  He was noted to be febrile, tachypneic in ER by chest x-ray was negative.  He tested positive for COVID-19 and was admitted. From a COVID-19 standpoint, patient was neither hypoxic nor had any infiltrates on chest x-ray.  His symptoms of cough and runny nose, unclear date of onset.  After discussion with family, patient will receive 3 day course of remdesivir with close monitoring of  liver function tests. PT/OT evaluated patient and recommended subacute rehab.  He was out of COVID isolation 10/19/22. Patient was discharged in stable condition to SAR.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea, Weight bearing difficulty
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/9/2022 Discharge Date: Oct 20, 2022  PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1] Acute on chronic encephalopathy likely toxic/metabolic in setting of COVID-19 infection exacerbated by underlying dementia HOSPITAL COURSE: Patient is 87-year-old male with the a PMH significant for BPH, hypothyroidism, insomnia and recent declining mentation over the last year is transferred to Hospital on 10/09 due to generalized weakness.  Normally patient is able to ambulate using a walker in his assisted living facility but suddenly was not able to stand up or bear weight and was noted to be more confused and perseverating on certain things.  He was noted to be febrile, tachypneic in ER by chest x-ray was negative.  He tested positive for COVID-19 and was admitted. From a COVID-19 standpoint, patient was neither hypoxic nor had any infiltrates on chest x-ray.  His symptoms of cough and runny nose, unclear date of onset.  After discussion with family, patient will receive 3 day course of remdesivir with close monitoring of  liver function tests. PT/OT evaluated patient and recommended subacute rehab.  He was out of COVID isolation 10/19/22. Patient was discharged in stable condition to SAR.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product preparation issue
Clinical narrative: this was a pediatric booster.  The stock vial was not diluted before 0.2ml was drawn out to be dosed.  As of 10/21/22 the father has indicated no side effects have been experienced.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Muscle twitching
Clinical narrative: Patient experienced numbness and twitching in his vaccinated arm. The numbness resolved by 7pm but patient has occasional twitching still at 7:10pm
Age: 40.0
Sex: F
Vaccine: UNK
Symptoms: Angiogram, Chest X-ray, Chest pain, Electrocardiogram, Troponin
Clinical narrative: chest pain, not consistent with pericarditis/myocarditis, after recieving Bivalent covid vaccine, patient is unsure which manufacturer
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Given non diluted dose
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood creatinine normal, Bursitis, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 19, 2022   PRESENTING PROBLEM: Dehydration [E86.0] Weakness [R53.1] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 76 y.o. male, with a PMH of ischemic cardiomyopathy, CHF, Afib, HTN, OSA, multiple myeloma, and primary appendiceal adenocarcinoma who presented to the ED with weakness. Patient was recently admitted from 10/8-10/12 with right septic olecranon bursitis/cellulitis treated with antibiotics, AKI and respiratory insufficiency due to COVID-19 infection. He was medically managed, weaned off oxygen, seen by PT/OT and discharged to home. At home he was not getting out of bed, not eating or drinking, and was weak without energy and brought back to the ER for further evaluation. On further interrogation he has been having diarrhea as well since starting Keflex and recent c.diff testing was negative. Given his weakness he was admitted to medicine for further evaluation.   He was found to have AKI. Given small fluid bolus, but AKI persisted. Workup consistent with pre-renal etiology with poor intake and diarrhea. Renal US without signs of hydronephrosis. Given more IV fluids and had resolution of AKI back to baseline Cr. He was evaluated by PT/OT who recommended home with assist. Given his good improvement he was discharged home in stable condition on 10/19/2022. He tolerated Keflex while inpatient and should complete previous course of Keflex at home.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cellulitis, Clostridium test negative, Decreased appetite, Dehydration, Diarrhoea
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 19, 2022   PRESENTING PROBLEM: Dehydration [E86.0] Weakness [R53.1] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 76 y.o. male, with a PMH of ischemic cardiomyopathy, CHF, Afib, HTN, OSA, multiple myeloma, and primary appendiceal adenocarcinoma who presented to the ED with weakness. Patient was recently admitted from 10/8-10/12 with right septic olecranon bursitis/cellulitis treated with antibiotics, AKI and respiratory insufficiency due to COVID-19 infection. He was medically managed, weaned off oxygen, seen by PT/OT and discharged to home. At home he was not getting out of bed, not eating or drinking, and was weak without energy and brought back to the ER for further evaluation. On further interrogation he has been having diarrhea as well since starting Keflex and recent c.diff testing was negative. Given his weakness he was admitted to medicine for further evaluation.   He was found to have AKI. Given small fluid bolus, but AKI persisted. Workup consistent with pre-renal etiology with poor intake and diarrhea. Renal US without signs of hydronephrosis. Given more IV fluids and had resolution of AKI back to baseline Cr. He was evaluated by PT/OT who recommended home with assist. Given his good improvement he was discharged home in stable condition on 10/19/2022. He tolerated Keflex while inpatient and should complete previous course of Keflex at home.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypophagia, Mobility decreased, Respiratory failure, Ultrasound kidney normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 19, 2022   PRESENTING PROBLEM: Dehydration [E86.0] Weakness [R53.1] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 76 y.o. male, with a PMH of ischemic cardiomyopathy, CHF, Afib, HTN, OSA, multiple myeloma, and primary appendiceal adenocarcinoma who presented to the ED with weakness. Patient was recently admitted from 10/8-10/12 with right septic olecranon bursitis/cellulitis treated with antibiotics, AKI and respiratory insufficiency due to COVID-19 infection. He was medically managed, weaned off oxygen, seen by PT/OT and discharged to home. At home he was not getting out of bed, not eating or drinking, and was weak without energy and brought back to the ER for further evaluation. On further interrogation he has been having diarrhea as well since starting Keflex and recent c.diff testing was negative. Given his weakness he was admitted to medicine for further evaluation.   He was found to have AKI. Given small fluid bolus, but AKI persisted. Workup consistent with pre-renal etiology with poor intake and diarrhea. Renal US without signs of hydronephrosis. Given more IV fluids and had resolution of AKI back to baseline Cr. He was evaluated by PT/OT who recommended home with assist. Given his good improvement he was discharged home in stable condition on 10/19/2022. He tolerated Keflex while inpatient and should complete previous course of Keflex at home.
Age: 26.0
Sex: U
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Effective beyond the administered day.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reactions noted.
Age: 26.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Effective beyond the administered day.
Age: 29.0
Sex: M
Vaccine: FLUC4
Symptoms: Pain, Pain in extremity
Clinical narrative: Patient called the pharmacy complaining of pain radiating underneath his arm into his shoulder. He currently is taking Tylenol to relieve the pain.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Chest X-ray normal, Dyspnoea, Influenza like illness, Peripheral swelling
Clinical narrative: I landed up with flu like symptoms and shortness of breath. After about 4 days the flu symptoms went away but the shortness of breath did not. Then my legs started to swell. My doctor sent me to the ER and they did testing. They found blood clots in my right calf. They kept me overnight for monitoring and they put me on ELIQUIS. I saw a pulmonologist and she thinks I might have a blot clot in my lungs so I am getting further tests.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Thrombosis, Ultrasound scan abnormal
Clinical narrative: I landed up with flu like symptoms and shortness of breath. After about 4 days the flu symptoms went away but the shortness of breath did not. Then my legs started to swell. My doctor sent me to the ER and they did testing. They found blood clots in my right calf. They kept me overnight for monitoring and they put me on ELIQUIS. I saw a pulmonologist and she thinks I might have a blot clot in my lungs so I am getting further tests.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Headache, Nasopharyngitis, Pain, Pyrexia
Clinical narrative: On 09/07/2022  at  01:00PM in the afternoon  I  felt like I was coming down with a cold. I had  mild symptoms such as runny nose, congestion, headache, body aches, and fever.  On the same day  I tested myself with a home test for COVID-19 which was positive. I  did a telehealth with my doctor on the same day. He prescribed  me medication for 5 days. I am not sure which medication it was but, It worked perfect.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On 09/07/2022  at  01:00PM in the afternoon  I  felt like I was coming down with a cold. I had  mild symptoms such as runny nose, congestion, headache, body aches, and fever.  On the same day  I tested myself with a home test for COVID-19 which was positive. I  did a telehealth with my doctor on the same day. He prescribed  me medication for 5 days. I am not sure which medication it was but, It worked perfect.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Bronchial wall thickening, COVID-19, Chest X-ray normal, Computerised tomogram abdomen abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/6/2022 Discharge Date: Oct 9, 2022  PRESENTING PROBLEM: Infarction of spleen [D73.5] Splenic infarct [D73.5] Splenic infarct in the setting of COVID infection Splenomegaly History of mild Von Willebrand syndrome Mild persistent asthma with mild exacerbation History of small lung nodule, remote history of smoking Abnormal left thigh lump HOSPITAL COURSE: Patient is a 74 y.o. female with past medical history significant for Von Willebrand syndrome, Lyme disease with chronic arthritis, former smoker, and mild intermittent ashtma on rescue inhaler who presented to emergency department with several months of cough, runny nose, "fevers", presented for abdominal pain and found to have splenic infarct and also COVID 19+. She has only had 1 J&J vaccine 11/2021.   Abdominal CT was done and showed a splenic infarct with splenomegaly.  Splenic infarct was thought to be 2/2 recent covid infection. She was seen by Hematology who felt in the absence of associated vessel thrombus, itself does not require anticoagulation. Data has shown no benefit with anticoagulation over aspirin for organ infarct. Given that she is already on ASA 81 mg daily long term, I recommended a short course of increased dose to 325 mg daily x 1 month, empirically in the setting of COVID+ and associated hypercoagulability with this. She conceded to two baby ASA tablets (= 162 mg) daily.  Echocardiogram was negative for cardio-embolic sources.   Hematology checked for other viral illnesses that can cause splenomegaly (EBV, CMV) and appropriate to screen for some hematologic conditions: 1) myeloproliferative condition with Jak2/MPN and BCR-ABL FISH. 2) PNH.  Most of these labs were pending at the time of discharge and will be followed up by Hematology who plan to see patient in their clinic outpatient.    Chest x-ray did not show evidence of lung infection. She has been on room air with O2 sat above 97%.  During the hospitalization, had a CT chest which showed Stable several a small 1-2 mm solid pulmonary nodule likely benign in etiology. New 3 mm groundglass nodule within the left upper lobe most likely due to infection and inflammation. Mild bronchial wall thickening due to infection or inflammation. No bronchiectasis. No focal airspace consolidation.  She was placed on a short course of prednisone due to her underlying asthma by Pulmonology.    A left UE soft tissue ultrasound shows an  Ill-defined focus of increased echogenicity within the subcutaneous fat of the anterior thigh correlates with the patient's palpable lump. Differential considerations would include a focus of fat inflammation versus a ill-defined hyperechoic mass. MRI LLE was recommended however,the patient opted to have it done outpatient with her PCP.   The patient was discharged in stable condition
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Cough, Cytomegalovirus test, Echocardiogram normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/6/2022 Discharge Date: Oct 9, 2022  PRESENTING PROBLEM: Infarction of spleen [D73.5] Splenic infarct [D73.5] Splenic infarct in the setting of COVID infection Splenomegaly History of mild Von Willebrand syndrome Mild persistent asthma with mild exacerbation History of small lung nodule, remote history of smoking Abnormal left thigh lump HOSPITAL COURSE: Patient is a 74 y.o. female with past medical history significant for Von Willebrand syndrome, Lyme disease with chronic arthritis, former smoker, and mild intermittent ashtma on rescue inhaler who presented to emergency department with several months of cough, runny nose, "fevers", presented for abdominal pain and found to have splenic infarct and also COVID 19+. She has only had 1 J&J vaccine 11/2021.   Abdominal CT was done and showed a splenic infarct with splenomegaly.  Splenic infarct was thought to be 2/2 recent covid infection. She was seen by Hematology who felt in the absence of associated vessel thrombus, itself does not require anticoagulation. Data has shown no benefit with anticoagulation over aspirin for organ infarct. Given that she is already on ASA 81 mg daily long term, I recommended a short course of increased dose to 325 mg daily x 1 month, empirically in the setting of COVID+ and associated hypercoagulability with this. She conceded to two baby ASA tablets (= 162 mg) daily.  Echocardiogram was negative for cardio-embolic sources.   Hematology checked for other viral illnesses that can cause splenomegaly (EBV, CMV) and appropriate to screen for some hematologic conditions: 1) myeloproliferative condition with Jak2/MPN and BCR-ABL FISH. 2) PNH.  Most of these labs were pending at the time of discharge and will be followed up by Hematology who plan to see patient in their clinic outpatient.    Chest x-ray did not show evidence of lung infection. She has been on room air with O2 sat above 97%.  During the hospitalization, had a CT chest which showed Stable several a small 1-2 mm solid pulmonary nodule likely benign in etiology. New 3 mm groundglass nodule within the left upper lobe most likely due to infection and inflammation. Mild bronchial wall thickening due to infection or inflammation. No bronchiectasis. No focal airspace consolidation.  She was placed on a short course of prednisone due to her underlying asthma by Pulmonology.    A left UE soft tissue ultrasound shows an  Ill-defined focus of increased echogenicity within the subcutaneous fat of the anterior thigh correlates with the patient's palpable lump. Differential considerations would include a focus of fat inflammation versus a ill-defined hyperechoic mass. MRI LLE was recommended however,the patient opted to have it done outpatient with her PCP.   The patient was discharged in stable condition